(CNN) -- The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades.

The success of suzetrigine supports the goal of moving beyond relieving pain to doing so safely, without perpetuating cycles ...

Dr. Reddy and Dr. Fuhrman from NexGenEsis Healthcare share how regenerative treatments help relieve pain without surgery or medication.

A phenomenon largely ignored since its discovery 100 years ago appears to be a crucial component of diabetic pain, according to new research from The University of Texas at Dallas's Center for ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

The medication initially known as VX-548 blocks sodium channels in nerves, blocking pain signals before they reach the brain ...

Pain is one of the most debilitating symptoms that presents with neuropathy. Neuropathic pain syndrome is a challenge to treat and, even with appropriate evidence-based treatment, only a 40% ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Hundreds of millions of people around the world experience chronic pain – meaning pain that lasts longer than three months. While the numbers vary from country to country, most studies estimate that ...

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a prescription pill that ...

Dr. Reddy and Dr. Fuhrman from NexGenEsis Healthcare share how regenerative treatments help relieve pain without surgery or medication.